TAHITI couples CRISPR with transposable elements from plants to edit cash crops such as corn and soybean with reduced ...

Imprint has raised $15 million to decode the body's immune memory for understanding chronic diseases, such as long-COVID and ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

Estrogen-related receptors (ERRs) regulate muscle mitochondria in mice, revealing a new potential drug targets for metabolic diseases.

CEO Serge Saxonov, PhD, acknowledged that its R&D operation “definitely ended up being impacted in a substantial way” while sales operations were less impacted since the company reorganized its sales ...

Treated with an individualized gene-editing therapy that corrects mutations directly on the genome, a patient shows improvement from a rare metabolic disease.

Current setbacks cannot prevent gene-editing companies from advancing closer to “one-and-done” cures and new products.

Some of the most widely used methods include a tangential flow filter (TFF). Instead of flowing through a filter, a sample ...

The French biotechnology firm aims to develop therapies for various neurological conditions using its non-replicating HSV-1 ...

Not designing with manufacturing in mind—even during early development—is a key reason fledgling biopharma companies fail.

In this Revvity GENCast episode 2, experts will discuss applications of gene editing to improve scientists’ understanding of ...

Montreal-based Nomic Bio broadens its proteomics technology to offer a 1,000-plex protein measurement service.